Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma?

Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease Early-phase experience with ruxolitinib suggests…

read more

The New York Post: One to watch before Academy Awards

A star-studded crowd is expected at a pre-Oscars bash to raise funds for the Institute…

read more

KFI/Patch Beverly Hills

Academy Award-Themed Event Raised Money for Cancer Research. BEVERLY HILLS, CA — The day the…

read more

HeySocal.com

Academy Award-themed event raised money for cancer research. The day the Academy Awards are given…

read more

MEDIA for IMBCR’s Pre-Oscar Benefit 3/12/23 at the WGA Theatre!

Celebrating “The Power and Magic of Music in Movies” on Oscar Day in Support of…

read more

EASTMAN WEEKLY News & Notes from the Eastman School of Music 3/20/23

Mark Watters speaking at the Institute for Myeloma and Bone Cancer Research fundraiser

read more

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

On the heels of his study, Dr. James Berenson —– an oncologist specializing in multiple…

read more

IMBCR & Emory University’s Big Discovery!!!

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response…

read more

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative…

read more

Dedication of “Determination”

The Institute for Myeloma & Bone Cancer Research (IMBCR) is pleased to announce the dedication…

read more